Skip to content
Baltimore News Journal – Lifestyle
Author:
ImmunoForge Co., Ltd.
ImmunoForge to Showcase Proprietary Platform Technologies and Next-Generation Oncology & Phase 2 Clinical Pipelines at BIO-Europe 2026
October 22, 2026